• DKSH posted H1 2026 net sales growth of 4.9% to CHF 5.5 billion, lifting core EBIT 3.6% to CHF 163.4 million.
• EPS climbed 18.2% to CHF 1.67, while the core EBIT margin narrowed 0.1 percentage point to 3.0%.
• Free cash flow rose to CHF 147.7 million, pushing cash conversion to 130.8%.
• Healthcare net sales increased 1.6% to CHF 2.86 billion, while Consumer Goods core EBIT fell 10.8% to CHF 34.1 million.
• DKSH expects a stronger H2 2026 and sees 2026 core EBIT higher than 2025, supported by business development, data centers and M&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DKSH Holding AG published the original content used to generate this news brief on July 17, 2026, and is solely responsible for the information contained therein.